Eli Lilly to apply for approval of anti-obesity drug retatrutide in 2027
The Eli Lilly logo appears at the company's office in San Diego, California, on November 21, 2025. Mike Blake |…
Novo Nordisk A/S
Employers Are Not Expanding Coverage of GLP-1 Anti-Obesity Drugs: Survey
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
Walmart and CVS step in to help seniors
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
Medicare Will Soon Cover Obesity Medications, But Many Seniors May Not Know It
Wegovy weight loss treatment injectable pens, manufactured by Novo Nordisk A/S, on display during a press conference in Mumbai, India,…
Estrogen patches in short supply as women seek menopause support
Woman applying estrogen patch during hormone therapy. Half point images | Moment | fake images Estrogen patches are in short…
UPS will invest $48 million in refrigeration facilities amid the LPG-1 boom
United Parcel Service (UPS) trucks are parked at a UPS warehouse on October 28, 2025 in Vernon, California. Mario Tama…
What's next for the weight-loss drug maker?
Shares in Danish biotech Zealand Pharma plunged recently after detailed data on its weight-loss drug survodutide showed much higher patient…
Lilly, Novo and Pfizer seek new weight loss drugs
Drug makers have only been introducing GLP-1 pills for a few months and are undergoing big changes to the way…
Novo Nordisk and Eli Lilly launch anti-obesity pills and prepare for Medicare coverage
Nordisk and Eli Lilly They took their battle against the GLP-1 pill to the biggest meeting on obesity this weekend…
Shares of weight-loss drug makers plunge 25% as safety data spooks investors
Shares in weight-loss drug maker Zealand Pharma plunged as much as 26% on Monday after new data on its experimental…